Related Experiment Video
Updated: Jul 7, 2026

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
Published on: June 9, 2022
Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient
Ashley R Mason1, Gil Y Cortes, Ross B Pollack
1Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Abstract:
Nevirapine is a non-nucleoside reverse transcriptase inhibitor commonly used in human immunodeficiency virus-1 multidrug regimens and associated with life-threatening cutaneous reactions. Here, we report the successful use of intravenous immunoglobulin in a pediatric patient with Stevens-Johnson syndrome and highlight the risk of nevirapine usage in human immunodeficiency virus postexposure prophylaxis.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Antiviral Nucleoside Inhibitors
Pharmacokinetics in Pediatric Patients: Drug Distribution
Cytomegalovirus Disease